November 10th – November 16th
In the general news, the U.S and China reached breakthrough agreement to curb greenhouse emissions. In Europe, Russia flagrantly invaded Ukraine with legions of tanks. In the U.S., the second round of enrollment for Obamacare was met with downgraded expectations from the White House.
In healthcare business news, Dendreon (DNDN) threw in the towel filing for bankruptcy.
On the data front, Achillion (ACHN) stock was up 28% when data supported their drug ACH-3102 when combined with Gilead’s (GILD) Sovaldi. Meanwhile, GILD’s Harvoni worked well in treatment failure HCV, and Abbvie’s (ABBV) Hep C drug Enanta worked in genotype 4 patients. In rheumatology, Amgen’s (AMGN) psoriasis drug brodalumab beat JNJ’s Stelara.